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INTRODUCTION: Upper extremity deep vein thrombosis is an increasingly important clinical ﬁnding
with signiﬁcant morbidity and mortality. The condition may be under-diagnosed in trauma and surgery
settings.
PRESENTATION OF CASE: We present a case of upper extremity thrombosis with venous congestive symp-
toms secondary to the use of an operative tourniquet. A literature review and discussion of the causeseywords:
eep vein thrombosis
ourniquet
pper extremity
rauma
of upper extremity deep vein thrombosis and the pathophysiological disturbances seen with tourniquet
use are presented.
DISCUSSION: Upper extremity deep venous thrombosis is uncommon. In this case the likely cause was
operative tourniquet use.
CONCLUSION: Operative tourniquet may be a risk factor in upper extremity deep vein thrombosis.
© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
he CCaccess article under t
. Introduction
Upper extremity (UE) deep venous thrombosis (DVT) accounts
or 4–10% of the 5–20 million cases of DVT that occur yearly in the
nited States.1 As with DVT of the lower extremity, thrombosis in
he upper extremity occurs due to hypercoagulability, venous sta-
is, or endothelial injury.2 Higher incidences of pulmonary emboli
PE), as high as 33% in patients with UEDVT, have been reported
ollowing an initial thrombus.3 Iatrogenic UEDVT requires fur-
her analysis to correct the offending problem and render proper
reatment. The condition may be under-diagnosed in trauma and
urgery settings when arm swelling and pain are common. We
resent a case of UEDVT of the upper extremity as the likely result
f prior trauma with subsequent use of upper extremity surgical
ourniquet.
. Presentation of case
An 83 year old male with no prior history of bleeding or clotting
isorder presented to the Emergency Department with a limited
eft forearm hematoma secondary to relatively minor blunt trauma
fter having his forearm caught in a closing door two weeks prior.
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The patient noted no signiﬁcant history of deep vein thrombo-
sis, pulmonary emboli, or any additional medical comorbidities
or medications that would increase risk of thromboembolus. Plain
ﬁlmX-ray revealed no fracture. No neurovascular ormusculoskele-
tal deﬁcits were appreciated on physical exam. Local swelling of
the left forearm and a 6 cm ﬂuid mass were observed/palpated. No
additional swellingof theextremitywasnoted. Patientwasbrought
to operating room for expanding hematoma evacuation and explo-
ration of upper extremity wound. Under regional Bier block with
operative tourniquet in place at 250mm Hg, surgical exploration
revealed subcutaneousoldandnewhematoma. Thehematomawas
evacuated with non-speciﬁc ﬁndings of mild oozing without a spe-
ciﬁc bleeding point. The forearm was irrigated with pulse lavage
and hemostasis was obtained. No other injuries were noted. Total
tourniquet time was 35min, with total sedation time 50min. The
tourniquet was released, hemostasis was assured and the wound
was closed in layers over a #10 Jackson-Pratt drain and soft dress-
ing applied. Blood pressure during surgical exploration remained
normotensive. During the post-operative period, drain output was
minimal (Figs. 1 and 2).
On post-operative day one, the patient was discharged to home
withminimal residual swellingof the left upper extremity.Onpost-
operative day 4, the patient returned for follow-up and was noted
to have signiﬁcant left upper extremity (LUE) swelling extend-
ing from the palm to the axilla. There did not appear to be free
ﬂuid on exam. Venous duplex scan demonstrated evidence of acute
thrombosis of the left internal jugular, subclavian and axillary
veins. No acute thrombuswas appreciated in the lower extremities.
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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eig. 1. (a–c): Photos taken at time of presentation with upper extremity deep vei
vidence of recurrent hematoma.
ypercoagulable workup, including platelet associated antibody
anel, antithrombin III, ProteinC, Protein S, haptoglobin, lupus anti-
oagulant, cardiolipin antibodies, factor V Leiden and prothrombin
ene mutation, was negative. The patient exhibited no signs or
ymptomatology suspicious for pulmonary embolus (PE). Treat-
ent included heparin drip followed by transition to coumadin.
ealing progressed without difﬁculty. The edema subsided over
he course of the following 3 weeks. Coumadin was continued for
months and then discontinued. Follow-up over the ensuing 18
onths revealed no further issues.
. Discussion
Upper extremity deep vein thrombosis (UEDVT) commonly
efers to thrombosis of the axillary and/or subclavian veins.4 Based
n the etiology of thrombus formation, UEDVT is either classiﬁed
s primary or secondary. Primary UEDVT is a rare disorder, result-
ng from thrombosis of the arm veinswithout evident predisposing
actors in the patient’s history.5 Pathogenesis of primaryUEDVT are
enous thoracic outlet syndrome, effort-related thrombosis (Paget-
chroetter Syndrome), and idiopathic.6
Approximately 66–80% of all reported UEDVT cases are sec-
ndary in nature.6 UEDVT is classiﬁed as secondary when
ndogenous or exogenous risk factors are known.5 Origins such
s central venous catheters (CVC), surgery or trauma of the arm or
houlder, andhypercoagulable states canusuallybe identiﬁed.1,3,4,6
oth malignancy-related and genetic hypercoagulable states have
een known to be etiologic factors.2
Multiple authors have reported correlations between recent
pper extremity operative procedures and upper extremity
VT.1,3,7,8 However, a large registryofUEDVTdiscovered thatmajor
urgical procedures, a conventional risk factor for lower-extremity
VT, did not predispose upper extremity DVT in patients who did
ot have a central venous catheter.9Arterial tourniquets are commonly used to achieve a blood-
ess operative ﬁeld. Deep venous thrombosis has been reported
t a higher incidence in a series of patients when lower extrem-
ty tourniquets were used to achieve a bloodless surgical ﬁeld.10
ig. 2. Oneweekafter initiationof anticoagulation therapy forupper extremitydeep
eing thrombosis. Photo demonstrates signiﬁcant improvement in upper extremity
dema.mbosis demonstrating signiﬁcant diffuse swelling of upper extremity. No clinical
Additionally, a number of reports describe new onset DVT and
pulmonary emboli (PE) as attributed to surgical tourniquet use
on the lower extremities.11 Because these reported patients suf-
fered fatal consequences secondary to DVT/PE, the use of lower
extremity tourniquet in high risk patients, such as thosewith lower
extremity trauma, prolonged immobilization, or history of venous
thromboembolism,may be contraindicated.12 No reports of UEDVT
as a consequence of upper extremity traumatic injury and use of
operative tourniquet were found upon review of the literature.
Two weeks prior to the tourniquet use, the patient sustained
a crush injury resulting in a local hematoma. Crush injuries result
in possible muscle injury, endothelial damage, and bleeding.13 The
loss of vascular integrity exposes the collagen-rich wall to platelet-
aggregation factors, activating the clotting cascade and causing the
release of procoagulant proteins. These proteins include tissue fac-
tor (TF), cytokines, and surface adhesion molecules that promote
leukocyte adhesion and thrombosis.
A number of physiologic disturbances that take place with
tourniquet usagemaypredispose to a thrombotic state. Application
of a tourniquet leads to venous stasis from the hand to the arm, vio-
lating the third aspect of Virchow’s triad.14 Circulating TF, released
by activation of leukocytes, accumulate in areas of stasis.13 Tourni-
quetuse then inducesan increase incirculating thromboticmarkers
of plasmin D-dimer, tissue plasminogen activator, angiotensin-
converting enzyme, antithrombin-III and protein C.15 Furthermore,
the activation pathways and feedback regulation shared by inﬂam-
mation and hemostasis are intensiﬁed by tourniquet use. Technical
errors during tourniquet placement may exacerbate the problem
as well. Slow inﬂation rates of pneumatic tourniquets can lead to
cessation of venous outﬂow while concomitantly allowing arterial
inﬂow, resulting in venous congestion. The same phenomenon can
also occur during deﬂation of the tourniquet, which should also be
performed as quickly as possible.8 These effects promote systemic
hypercoagulability.
Numerous disturbances of the coagulation cascade have been
described both intraoperatively and after deﬂation of a tourniquet.
In animal studies, a hypercoagulable state was observed 60min
after placement of a circumferential Esmarch bandage.16 Platelet
aggregation was signiﬁcantly elevated due to tissue compression
of the limb. Human studies have shown that the pain induced
by initial tourniquet inﬂation increases levels of catecholamines
and serotonin intravascularly, thereby increasing platelet aggre-
gation, without an increase in ﬁbrinolysis.17 The combination of
these factors predisposes to a procoagulant state in the compressed
extremity and likely contributes to DVT formation.
There is no consensus on a “safe” period of time for upper
extremity tourniquet, although a commonly utilized guideline sug-
gests compression for no longer than 120min, mostly to avoid
excessive warm ischemia time. This may also minimize stasis time
before allowing reperfusion.18
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Our patient had no previous history of DVT or prior risk factors
or hypercoagulability and did not have a central venous catheter
nsertion. His Caprini Risk Assessment model (RAM) score was 5;
ge >75, 3 points +major surgery, 2 points; under the venous RAM
core for consideration of chemical prophylaxis. During the time
ine of forearm injury until surgical intervention (two weeks), the
atient did not exhibit signs or symptoms of upper extremity DVT.
he presentation with an extensive DVT four days post-operatively
ppears to be due to the use of the intra-operative tourniquet. The
nitial crush injury, though relatively minor in severity, may have
ed to a predisposed hypercoagulable state exacerbated by tourni-
uet use. Surgeons should be aware of the potential risk of upper
xtremity tourniquet use in patients, especially those with recent
raumatic injury. This combinationmay lead toDVToccurrence and
otential risks of DVT associated complications.
. Conclusion
Deep vein thrombosis is an increasing problem in the United
tates. There are a number of mechanisms, which cause sec-
ndary thrombosis including malignancy, trauma, central venous
atheters, and circumferential compression, as with surgical
ourniquets. The various pro-coagulant disturbances in the coag-
lation cascade and venous stasis experienced with the use of a
ourniquet necessitate greater attention to patient factors which
ould increase the risk of upper extremity DVT. If tourniquet use is
esirable or unavoidable in patients with a history of hypercoagu-
ability, cancer, operative area trauma, or indwelling intravenous
atheters, a high index of suspicion for DVT and its symptoms
hould be maintained. If not necessary, tourniquet use should be
inimized, especially with these risk factors. While the risk of
hrombosis may be a minor consideration when compared to the
ase of operation in a bloodless ﬁeld, surgeons cannot invariably
eny that upper extremity tourniquet usage may lead to VTE in
igh-risk patients.
Caprini VTE Risk Assessment scores should be utilized as an
ndicator of those at signiﬁcant risk for VTE.19,20 Though the
odel/score does not assess tourniquet use or upper extremity
urgical procedures speciﬁcally (other than central venous access),
erhaps these factors should be considered in each individual’s risk
ssessment.
We report here a case of upper extremity deep vein thrombosis,
tatus posttraumatic crush injury with use of operative tourniquet.
ur literature search revealed no prior reports of similar cases.
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